Lornoxicam With Low Dose Ketamine Versus Pethidine to Control Pain of Acute Renal Colic
NCT ID: NCT03780556
Last Updated: 2018-12-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2016-01-02
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Analgesic Drugs in Renal Colic in Emergency Room
NCT03278652
Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients
NCT05776953
Nasal Fentanyl And Renal Colic
NCT01339624
Low-dose Ketamine for Acute Pain in the Emergency Department
NCT03017248
Pramipexole and Morphine for Renal Colic
NCT04160520
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lornixicam
Patients received lornoxicam 8 mg intravenous to control pain
Lornoxicam and mepridine
compare the effect of each to control pain
Pethidine
Patients received pethidine 50mg intravenous to control pain
Lornoxicam and mepridine
compare the effect of each to control pain
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lornoxicam and mepridine
compare the effect of each to control pain
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients aged between 20-60 years.
Exclusion Criteria
* liver and renal failure
* hypersensitivity to lornoxicam, ketamine and pethidine, history of peptic ulcer,
* gastrointestinal bleeding and perforation,
* hypertensive and history of cardiac diseases
* pregnancy and lactation and
* urine examination showing more than 5 leukocytes suggestive of pyuria.
* patients with hyperthyroidism are excluded
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayman Anis Metry
Assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ِAin Shams University hospitals
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASU 5418
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.